Member Info for gggg21

https://twitter.com/AshfieldEngage/status/1479137490128838657

WHO currently talking 1) Treatments need to be shared with the world 2) With all the cases going on another new variant will come along shortly 3) Until 70% of the world is vaccinated we will not see the end of covid 4) Omicron should not be classified as mild 5) Healthcares are crippling under surge in cases and deaths are creeping up 6) Highest ever number of cases globally yesterday

BARDA

Numis broker note was even more bullish, they maybe updating theirs in readiness....

Agree Matml74 - i stand by my manic monday 10th january as i stated earlier. The timeline in terms of number of days from p2 completion to readout matches similarly with p3 ending 10th Nov, data mid december and then readout. The tweet yesterday, this news today, the fact you can prep the media over weekend for monday morning headlines and then the fact Synairgen are not going or participating at the HC wainwright conference, one of the largest bio conferences which nearly every pharma is at (this is on 10th to 13th Jan) says to me synairgen are busy...

BARDA

The US backed and funded activ-2 trial, there is further funding and grants available...US are clearly paying up so they have the first dibs. Nice dig at the UK

which will see us recruiting experts to support delivery of this novel nebulised antiviral to patients, providing MSLs to educate on the SNG001 treatment, and establishing medical information services to respond to patient enquiries."

It’s all coming together. They know they have the data. Look at last line about financials to interesting

https://www.finncap.com/research-portal you need to register it here, I am not sharing the print outs on twitter as it has copyright infringements and they know who posted it, so i do not want to lose access. Just register free of charge and you will be able to download easy

Covid times are exceptional, we had warnings of SARS previously and finally got hit, covid type viruses are here to stay. The market for therapeutics is very thin especially in hospital settings for any antiviral/therapeutic and synairgen p2 results were outstanding hence being US backed and funded on the NIH activ-2 trial. The figures Pfizer and the like are getting from US orders alone are currently upwards of 6bn for their pill....so yeh you can see why these figures are being mentioned.

This broker note came from the in house broker finncap interesting timing and narrative in the full note almost as if they are prepping for something like yesterday tweet

In the immediate term, we increase our target price to 530p from 505p, to reflect the likelihood that Synairgen will receive initial purchase orders from governments immediately following EUA Assuming Key estimates a positive Phase III readout , our target price would rise to 728p

Monday 10th jan just like last time with p2 results it gives them the weekend to prep the media etc for Monday morning news headlines without any “leaks” as market closed. I also noted that Synairgen aren’t attending the hc wainwright conference that so many other pharmas are, this is on 10th -13th January so clearly Synairgen are busy ;) have something else planned

Yep you done the same calculations as myself i gave a few days either way as last time was completion end of week then weekend in way and weekend before manic monday so they likely had everything ready say on the friday before. I have stated that the window for results is beginning of next week onwards - especially given the proactive interview and about hoping to finish trial October to get results just before end of year, so given it was 10th Nov completion done.....

If you check the full details of the clinical trial there was a mid point check on data to judge whether the trial should continue or not, the company is not privy to this. All the documentation is in the public domain for the full detail.

The data is sent in and held as and when, it is held privately usually with the clinical trial partner remember that day 35 is for the very last recruit....

Cheers Matml74 just so much going on behind the scenes so fast currently. Probably have a nice Argentinian steak later like some of the synairgen team probably enjoyed lately

i have googled and looked, not a mention in any sentence together, the only mention of them together on internet is on UK gov life sciences long list and IQIVA mentioning AZ and Synairgen deal in the past otherwise no matches what so ever. Why mention it now?

First mentioned today in synairgen tweet, no reference anywhere of this before ever as far as i can see in company news, google anywhere. IQIVA are mcap 50bn us dollars listed on US stock exchange. They do 11.3bn in revenue in 2020

Amazing tweet they have had the data now for at least 3 weeks now. No wonder management have been racking up the air miles of late